m+Medelevator.RU
← Поиск публикаций
Oral diseases · 2026

Adjunctive Low-Intensity Pulsed Ultrasound Therapy for Bone Regeneration Following Jaw Cyst Enucleation With Curettage.

СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Elayah Sadam Ahmed, Hu Wenzhong, Zhang Ruitao, Gao Xinzhe, Han Cong, Long Jie

Аннотация

OBJECTIVE: This trial aimed to assess the adjunctive therapeutic effect of low-intensity pulsed ultrasound (LIPUS) in promoting bone regeneration following jaw cyst enucleation with curettage.

METHODS: This triple-blinded, randomized trial enrolled 29 patients (33 jaw cysts) undergoing enucleation. 17 patients (18 cysts) received daily LIPUS therapy for 10 days (Ultrasound group), while 12 patients (15 cysts) received sham LIPUS therapy (control group). Volumetric changes of the cystic cavities and bone density (relative Hounsfield units) were assessed at baseline, at 3, and 6 months following LIPUS therapy.

RESULTS: At the 3rd month, a significant reduction in cyst volume was observed in the Ultrasound group, which showed a 63% reduction, compared to a 35% reduction in the control group (p = 0.031). By the 6th month, the Ultrasound group demonstrated a further decrease in volume compared to the control group (82% vs. 61%; p = 0.027). Moreover, LIPUS therapy consistently resulted in significantly greater bone density than the control group at both 3 and 6 months (p = 0.026 and p = 0.031, respectively).

CONCLUSIONS: Adjunctive LIPUS therapy following jaw cyst enucleation improves bone regeneration postoperatively without adverse effects. LIPUS is a promising non-invasive method for promoting bone healing post-enucleation.

TRIAL REGISTRATION: Thailand Clinical Trials Registry on June 16, 2025 (https://www.thaiclinicaltrials.org/show/TCTR20250616017).

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты